OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atopic dermatitis: Is innate or adaptive immunity in control? A clinical perspective
Peck Y. Ong
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases
Burkhard Kleuser, Wolfgang Bäumer
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1456-1456
Open Access | Times Cited: 26

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
Maddalena Napolitano, Francesca di Vico, Angelo Ruggiero, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 26

Skin microbiota: pathogenic roles and implications in atopic dermatitis
Cong Huang, Fan Zhuo, Yang Guo, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1

Gut microbiota and skin pathologies: Mechanism of the gut-skin axis in atopic dermatitis and psoriasis
Meng Chen, Rui Wang, Ting Wang
International Immunopharmacology (2024) Vol. 141, pp. 112658-112658
Closed Access | Times Cited: 6

Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis
Linda Stein Gold, Wynnis L. Tom, Vivian Y. Shi, et al.
Dermatitis (2024) Vol. 35, Iss. 1, pp. 84-91
Open Access | Times Cited: 5

Aspalathin, a key flavonoid in rooibos, restores STAT6-mediated immune dysregulation in atopic dermatitis
In‐Young Yang, Na‐Hee Jeong, Young‐Ae Choi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117926-117926
Closed Access

Immune Memory: A New Frontier in Treating Recurrent Inflammatory Skin Diseases
Hang Yin, Jianru Chen, Chunying Li
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access

Pulsatilla koreana Nakai Extract Attenuates Atopic Dermatitis-like Symptoms by Regulating Skin Barrier Factors and Inhibiting the JAK/STAT Pathway
Hye Jin Kim, Musun Park, Seol Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2994-2994
Open Access

Cure for the itch: current clinical standards and therapies in allergic eczema
Jennifer E Lazor, Bree A Bozsoki, Prashant Bharadwaj
Frontiers in Allergy (2025) Vol. 6
Open Access

Inhibition of macrophage MAPK/NF-κB pathway and Th2 axis by mangiferin ameliorates MC903-induced atopic dermatitis
Cheng Lü, ShiJun Deng, Yanjiao Liu, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112038-112038
Closed Access | Times Cited: 3

An AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes skin homeostasis against atopic dermatitis
Zeyu Chen, Morgan Dragan, Peng Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Association Between Atopic Dermatitis and Aging: Clinical Observations and Underlying Mechanisms
Peng‐Yu Chen, Minxue Shen, Sui‐Qing Cai, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3433-3448
Open Access | Times Cited: 2

Polysaccharide-based hydrogels for atopic dermatitis management: A review
Harinash Rao, Joash Ban Lee Tan
Carbohydrate Polymers (2024) Vol. 349, pp. 122966-122966
Open Access | Times Cited: 2

Recent advances in immunomodulators for atopic dermatitis
Hyun Jin Yim, Tiffany Jean, Peck Y. Ong
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 6, pp. 671-679
Closed Access | Times Cited: 6

Qingre Qushi formula suppresses atopic dermatitis via a multi-target mechanism
Dongming Wang, Xin Ma, Zhi-Ao Xu, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116923-116923
Closed Access | Times Cited: 5

CERS1 is a Biomarker of Staphylococcus aureus Abundance and Atopic Dermatitis Severity
H. Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 1

IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn?
Charles F. Schuler, Jóhann E. Guðjónsson
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 6, pp. 1410-1411
Open Access | Times Cited: 6

Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials
Ogechi Obed, Albert C. Chong, Malcolm Su, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 233-249
Closed Access

Interferon gamma as a trigger of chronic viral infections and inflammatory dermatoses
E.Yu. Evdokimov Evdokimov, E.V. Svechnikova Svechnikova, Ж.Б. Понежева
Meditsinskiy sovet = Medical Council (2024), Iss. 5, pp. 214-220
Open Access

Features of the clinical course of the disease, quality of life and systemic cytokine profile in patients with chronic true eczema and depression
Ф.С. Асанова, Т.А. Москвина, М.Н. Шабутова, et al.
International journal of medicine and psychology. (2024) Vol. 7, Iss. 3, pp. 86-94
Closed Access

Page 1 - Next Page

Scroll to top